OLMA - Olema Oncology to Participate in Upcoming Investor Conferences in November | Benzinga
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema", "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers, today announced that the Company will present at the following upcoming investor conferences in November:
- Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the Jefferies London Healthcare Conference at The Waldorf Hilton in London, UK, on Wednesday, November 15, 2023, at 12:30 p.m. GMT (7:30 a.m. ET).
- Dr. Bohen will participate in a Fireside Chat at the 6th ...